Attachment C - Schedule of Services.xlsx

XLSX spreadsheet 79 KB Posted Aug 3, 2021

Attached to: Q301--Tumor Normal Matched Genomic Testing Services Federal contract opportunity
Solicitation number: 36C10G21R0015
Issued by: Department of Veterans Affairs Headquarters

About this file

Written by GovTribe AI · Dec 30, 2023

This document includes an Independent Government Cost Estimate (IGCE) and related federal contract opportunity solicitation. The IGCE provides quarterly and annual volume projections for genomic testing services for prostate and breast cancer samples through 2025, with estimated costs per sample and total costs by fiscal year. The related solicitation seeks offers for Tumor Normal Matched Genomic Testing Services under solicitation number 36C10G21R0015 from the Department of Veterans Affairs. Offerors must submit all questions by August 13, 2021 and final proposals are due by September 1, 2021. The solicitation appears to require genomic testing services matching tumor and normal tissue samples for cancer patients.

View the file

Other files for this federal contract opportunity

Other files attached to Q301--Tumor Normal Matched Genomic Testing Services, newest first.
File	Type	Posted
Attachment F rev 1 - Past Performance Questionnaire.docx	DOCX document	Aug 16, 2021
Attachment C rev 1- Schedule of Services.xlsx	XLSX spreadsheet	Aug 16, 2021
36C10G21R0015 0001.docx	DOCX document	Aug 16, 2021
36C10G21R0015 0001_1.docx	DOCX document	Aug 16, 2021
Attachment E- Technical Evalulation Matrix.xls	XLS spreadsheet	Aug 3, 2021
Attachment A - Quarterly Sales Report QSR.xlsx	XLSX spreadsheet	Aug 3, 2021
Attachment D - Pay.gov Vendor Submittal Instructions.docx	DOCX document	Aug 3, 2021
36C10G21R0015_1.docx	DOCX document	Aug 3, 2021
Attachment F - Past Performance Questionnaire.docx	DOCX document	Aug 3, 2021
Attachment B - Sample Business Associate Agreement.pdf	PDF	Aug 3, 2021
RFP Tumor Normal Testing 36C10G21R0015.docx	DOCX document	Aug 3, 2021

Show all 11

On GovTribe

Work with this file on GovTribe

Download the original file
Contacts named in this file
Similar government files
Ask GovTribe AI about this file

Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

IGCE

Quarterly Volumes of Prostate Cancer samples through the National Precision Oncology Program
	PROSTATE	Year over year increase	Comments
1Q20	326
2Q20	397
3Q20	431
4Q20	405
1Q21	471	44.48%	Large growth from 2020 to 2021 is not expected to continue year over year. Estimate higher growth in early years that will likely slow down in subsequent years. Maximum number of patients with metastatic prostate cancer eligible for testing is expected to be ~ 9000

	Breast
Q1-Q4 2020	91

		Comments
Test Cost Estimate (per paired tumor normal sample)	$2,500
Test Volume Estimate (per year)	2844.0	Based on 1Q21 numbers + 44% increase (Breast + Prostate)
	Total $	Total Estimated Tests	Assumptions
FY21	$7,110,000	2,844	44% growth over 2021
FY22	$9,243,000	3,697	30% growth over 2022
FY23	$12,015,900	4,806	30% growth over 2023
FY24	$15,620,670	6,248	30% growth over 2024
FY25	$20,306,871	8,123	30% growth over 2025
TOTAL	$64,296,441
Break-out by Clin
FY21		2,844
	001	500
	002	500
	003	500
	004	500
	005	844
FY22		3,697
	001	650
	002	650
	003	650
	004	650
	005	1,097
FY23		4,806
	001	845
	002	845
	003	845
	004	845
	005	1,426
FY24		6,248
	001	1,099
	002	1,099
	003	1,099
	004	1,099
	005	1,854
FY25		8,123
	001	1,428
	002	1,428
	003	1,428
	004	1,428
	005	2,411

Schedule_ajr

CLIN

Item Number

SLIN

Description

Ref CLIN

Comment

Include Comments in Document

Contract Period

Pop Begin

Pop End

Quantity

Unit of Measure

Receipt Type

Line Item Is

Unit Price

Item Discount Type Name

Item Discount

Date Updated

Address1

Address2

Address3

City

State

Zip

Zip4

Country

Mark For

Contact Name

Contact Phone

Contact Email

Delivery Date

FOB

Include Instructions/Comments in Document

PRINCIPAL NAICS CODE

PRODUCT/SERVICE CODE

MANUFACTURER PART NUMBER (MPN)

LOCAL STOCK NUMBER

DM DOC ID

DELIVERY REF. COUNTER

UNIT TEXT/DESCRIPTION

DELIVERY REFERENCE

ITEM MASTER FILE NUMBER

EXPENDABLE/NON-EXPENDABLE

QUANTITY REQUESTED

UNIT OF PURCHASE CODE

UNIT OF PURCHASE TEXT/DESC.

NDC

FOOD GROUP CODE

NIF ITEM NUMBER

MINIMUM ORDER QUANTITY

001

Tumor Normal NGS Panel with reports

Base

500

621511

Q301

002

Tumor NGS Panel (in absence of normal sample) with reports

Base

500

621511

Q301

003

Tumor Normal NGS Whole Exome with reports

Base

500

621511

Q301

004

Tumor NGS Whole Exome (in absence of normal sample) with reports

Base

500

621511

Q301

005

Liquid Biopsy NGS (tissue insufficient) with reports

Base

844

621511

Q301

1001

Tumor Normal NGS Panel with reports

Option 1

650

621511

Q301

1002

Tumor NGS Panel (in absence of normal sample) with reports

Option 1

650

621511

Q301

1003

Tumor Normal NGS Whole Exome with reports

Option 1

650

621511

Q301

1004

Tumor NGS Whole Exome (in absence of normal sample) with reports

Option 1

650

621511

Q301

1005

Liquid Biopsy NGS (tissue insufficient) with reports

Option 1

1097

621511

Q301

2001

Tumor Normal NGS Panel with reports

Option 2

845

621511

Q301

2002

Tumor NGS Panel (in absence of normal sample) with reports

Option 2

845

621511

Q301

2003

Tumor Normal NGS Whole Exome with reports

Option 2

845

621511

Q301

2004

Tumor NGS Whole Exome (in absence of normal sample) with reports

Option 2

845

621511

Q301

2005

Liquid Biopsy NGS (tissue insufficient) with reports

Option 2

1426

621511

Q301

3001

Tumor Normal NGS Panel with reports

Option 3

1099

621511

Q301

3002

Tumor NGS Panel (in absence of normal sample) with reports

Option 3

1099

621511

Q301

3003

Tumor Normal NGS Whole Exome with reports

Option 3

1099

621511

Q301

3004

Tumor NGS Whole Exome (in absence of normal sample) with reports

Option 3

1099

621511

Q301

3005

Liquid Biopsy NGS (tissue insufficient) with reports

Option 3

1854

621511

Q301

4001

Tumor Normal NGS Panel with reports

Option 4

1428

621511

Q301

4002

Tumor NGS Panel (in absence of normal sample) with reports

Option 4

1428

621511

Q301

4003

Tumor Normal NGS Whole Exome with reports

Option 4

1428

621511

Q301

4004

Tumor NGS Whole Exome (in absence of normal sample) with reports

Option 4

1428

621511

Q301

4005

Liquid Biopsy NGS (tissue insufficient) with reports

Option 4

2411

621511

Q301

Sheet1_OGC_original

CLIN

Item Number

SLIN

Description

Specialized Category

Ref CLIN

Comment

Include Comments in Document

Contract Period

Pop Begin

Pop End

Quantity

Unit of Measure

Packaging Multiple

Receipt Type

Line Item Is

Unit Price

Item Discount Type Name

Item Discount

Date Updated

Address1

Address2

Address3

City

State

Zip

Zip4

Country

Mark For

Contact Name

Contact Phone

Contact Email

Delivery Date

FOB

Special Instructions

Include Instructions/Comments in Document

PRINCIPAL NAICS CODE

PRODUCT/SERVICE CODE

UNSPSC

SIC CODE

MANUFACTURER PART NUMBER (MPN)

NATIONAL STOCK NUMBER

LOCAL STOCK NUMBER

DM DOC ID

DELIVERY REF. COUNTER

UNIT TEXT/DESCRIPTION

DELIVERY REFERENCE

ITEM MASTER FILE NUMBER

EXPENDABLE/NON-EXPENDABLE

QUANTITY REQUESTED

001

Tumor Normal NGS Panel

Base

500

621511

Q301

002

Tumor NGS Panel (in absence of normal sample)

Base

500

621511

Q301

003

Tumor Normal NGS Whole Exome

Base

500

621511

Q301

004

Tumor NGS Whole Exome (in absence of normal sample)

Base

500

621511

Q301

005

Liquid Biopsy NGS (tissue insufficient)

Base

844

621511

Q301

1001

Tumor Normal NGS Panel

Option 1

500

621511

Q301

1002

Tumor NGS Panel (in absence of normal sample)

Option 1

500

621511

Q301

1003

Tumor Normal NGS Whole Exome

Option 1

500

621511

Q301

1004

Tumor NGS Whole Exome (in absence of normal sample)

Option 1

500

621511

Q301

1005

Liquid Biopsy NGS (tissue insufficient)

Option 1

844

621511

Q301

2001

Tumor Normal NGS Panel

Option 2

500

621511

Q301

2002

Tumor NGS Panel (in absence of normal sample)

Option 2

500

621511

Q301

2003

Tumor Normal NGS Whole Exome

Option 2

500

621511

Q301

2004

Tumor NGS Whole Exome (in absence of normal sample)

Option 2

500

621511

Q301

2005

Liquid Biopsy NGS (tissue insufficient)

Option 2

844

621511

Q301

3001

Tumor Normal NGS Panel

Option 3

500

621511

Q301

3002

Tumor NGS Panel (in absence of normal sample)

Option 3

500

621511

Q301

3003

Tumor Normal NGS Whole Exome

Option 3

500

621511

Q301

3004

Tumor NGS Whole Exome (in absence of normal sample)

Option 3

500

621511

Q301

3005

Liquid Biopsy NGS (tissue insufficient)

Option 3

844

621511

Q301

4001

Tumor Normal NGS Panel

Option 4

500

621511

Q301

4002

Tumor NGS Panel (in absence of normal sample)

Option 4

500

621511

Q301

4003

Tumor Normal NGS Whole Exome

Option 4

500

621511

Q301

4004

Tumor NGS Whole Exome (in absence of normal sample)

Option 4

500

621511

Q301

4005

Liquid Biopsy NGS (tissue insufficient)

Option 4

844

621511

Q301

OGC question

Response I changed the quantities (see "Schedule_ajr") to match the number of cases on the IGCE. Not certain about the cost/test being different, will discuss at 6/30 mtg.-ajr image1.tmp

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it. Updated Aug 3, 2021.